From the Journals

Proximal adenoma location does not predict high-grade dysplasia

View on the News

High-quality colonoscopy is the bottom line

Colorectal cancers detected in a short interval after a complete and clearing colonoscopy are referred to as postcolonoscopy colon cancers or interval cancers, and are approximately three times more likely to occur in the proximal colon compared with the distal colon. Reasons for this difference are not known and possible explanations include alternate and accelerated tumor biology and rapid cancer progression, such as through the CpG island methylation phenotype pathway, missed cancers or precursor lesions in the proximal colon, or incomplete polyp resection. In the current study, the authors address whether the biology of polyps removed in the proximal colon is different, i.e., are these adenomas more likely to exhibit high-grade dysplasia compared to adenomas in the distal colon in approximately 2.5 million screening colonoscopies performed between 2007 and 2012, obtained from a screening colonoscopy registry in Germany. The authors did not find a difference in frequency of high-grade dysplasia between proximal and distal polyps. As expected, adenoma size, male sex, and older age were associated with finding of high-grade dysplasia, but contrary to current literature, the authors found that distal location and pedunculated (versus sessile) form were associated with high-grade dysplasia. A major limitation of the study is that sessile serrated polyps were not included, and the authors did not have information on villous histology. The study reinforces the hypothesis that missed and incompletely resected adenomas play a bigger role in missed proximal cancers, and that the goal of high-quality colonoscopy should be to detect and completely resect adenomas with equal vigilance in both the proximal and distal colon.

Dr. Aasma Shaukat, professor of medicine, division of gastroenterology and hepatology, University of Minnesota, Minneapolis

Dr. Aasma Shaukat

Aasma Shaukat, MD, MPH, AGAF, is professor of medicine in the division of gastroenterology and hepatology at the University of Minnesota, Minneapolis, and the GI Section Chief at the Minneapolis VA Medical Center. She has no conflicts of interest.


 

FROM CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Proximal adenoma location did not predict high-grade dysplasia in a large registry study.

In fact, the odds of high-grade dysplasia were about 25% lower for proximal versus distal adenomas (odds ratio, 0.75), reported Thomas Rösch, MD, of University Hospital Hamburg-Eppendorf, Hamburg, Germany, and his associates. A third of adenomas in the study lacked location data, but in sensitivity analyses, the odds of high-grade dysplasia fell to 0.72 when these lesions were assumed to be proximal and rose to 0.96 when they were assumed to be distal.

Interval colorectal cancers probably are more likely to be proximal than distal because of a “combination of endoscopy-related factors and biology,” not because of histologic differences alone, the researchers wrote. The report was published in Clinical Gastroenterology and Hepatology.

Interval cancers are more common in the right colon, as several studies have noted. However, it was unclear whether this phenomenon represented a higher miss rate, a lower rate of successful polypectomy, or an increased risk of malignant histology in the proximal colon, the researchers wrote. Accordingly, they analyzed data on 594,614 index adenomas detected during more than 2.5 million screening colonoscopies performed between 2007 and 2012 and entered into the German National Screening Colonoscopy Registry.

A total of 3.5% of index adenomas showed high-grade dysplasia, which correlated most strongly with larger size, said the researchers. In fact, the odds of high-grade dysplasia were 10-fold higher when index adenomas measured at least 1 cm than when they were smaller. High-grade dysplasia also was significantly more frequent when patients were older than 64 years, were male, and when they had pedunculated versus flat lesions. Given the large size of the dataset, all these associations were statistically significant.

Sessile lesions were slightly more likely to be high-grade compared with flat lesions, the investigators noted. Many proximal interval cancers arise from sessile serrated polyps, which may be subtle and difficult to detect or to resect completely, they continued. At the same time, colonoscopy also might be more likely to miss flat, serrated lesions when they are located proximally, and these lesions can become more aggressive over time. Thus, “[e]ndoscopist factors, such as missed lesions or incompletely removed lesions, may account for the predominance of proximal interval colorectal cancers.”

Like other registry studies, this study lacked uniform histopathologic definitions or central histopathology review. The dataset also covered only the largest or most histologically remarkable adenoma for each patient. However, the study findings did not change substantially after the researchers controlled for patients with missing location data, which presumably included patients with multiple polyps in both proximal and distal locations.

The researchers did not disclose external funding sources. They reported having no conflicts of interest.

SOURCE: Rösch T et al. Clin Gastroenterol Hepatol. 2018 Jun 11. doi: 10.1016/j.cgh.2018.05.043.

Recommended Reading

Cirrhosis study finds no link between screening, liver cancer mortality
MDedge Hematology and Oncology
Proinflammatory diet linked to colorectal cancer testing positive for Fusobacterium nucleatum
MDedge Hematology and Oncology
Commentary: Composite risk, not age, is key for timing first colorectal cancer screening
MDedge Hematology and Oncology
Colonoscopy: Should 45 be the new 50?
MDedge Hematology and Oncology
Dramatic response from pembrolizumab in patient with Lynch syndrome
MDedge Hematology and Oncology
Rivaroxaban bonus: Early unmasking of occult GI cancers
MDedge Hematology and Oncology
First combo trial of mTOR/BRAF inhibition shows potential
MDedge Hematology and Oncology
Mutation in patients with chronic HCV raises risk of liver cancer
MDedge Hematology and Oncology
JACOB: Dual HER2 blockade falls short in metastatic gastric cancer
MDedge Hematology and Oncology
Guideline: Early screening warranted if family history of nonhereditary colorectal cancer
MDedge Hematology and Oncology